Vaccination with a multi‐epitopic recombinant allergen induces specific immune deviation via T‐cell anergy

Authors:

Abstract
Prophylactic vaccination has recently emerged as a major paradigm toward the prevention and therapy of allergies and asthma; however, the immunological basis of this approach remains to be elucidated. We examined the potential and mechanism of prophylaxis of allergic response in B6D2F1 mice with a multi‐epitopic recombinant allergen, rKBG8·3 (MERA‐8·3), which represents a major group of allergens of grass pollens, used herein as a model of MERA vaccine. Vaccination (subcutaneous) with soluble MERA‐8·3, prior to immunization with the MERA‐8·3 in alum, led to suppression of the IgE antibody response and a concomitant increase in IgG2a antibody response specific to the MERA‐8·3 in a dose‐dependent manner. Analysis of cytokine patterns in spleen and lymph node cells revealed a marked decrease of interleukin‐2 (IL‐2) and IL‐4 production and to a lesser extent a decrease of interferon‐γ (IFN‐γ) synthesis, resulting in an increased ratio of IFN‐γ:IL‐4 in vaccinated–immunized mice compared with untreated–immunized control mice. Furthermore, splenocytes of mice treated with the MERA‐8·3 alone proliferated to MERA‐8·3 in vitro with reduced capacity compared with the splenocytes of MERA‐8·3‐alum immunized mice, owing to a markedly reduced level of IL‐2 production in the former. Collectively, these results suggest that vaccination with the MERA‐8·3 induces T‐cell anergy, which is pivotal to deviation of specific immunity from Th2‐ to Th1‐like, and may serve as an important approach to prevention and therapy of allergic disorders.

This publication has 24 references indexed in Scilit: